Penumbra (PEN) Shares Outstanding (Weighted Average) (2014 - 2026)

Penumbra (PEN) reported Shares Outstanding (Weighted Average) of $39.3 million for Q1 2026, up 1.85% year-over-year from $38.6 million in Q1 2025, and up 0.92% quarter-over-quarter from $38.9 million in Q4 2025.

Penumbra (PEN) Shares Outstanding (Weighted Average) (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Shares Outstanding (Weighted Average) data on file, last reported at $39.3 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $39.3 million, up 1.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.3 million (up 1.85% YoY), and the FY2025 annual result was $38.9 million, up 0.74% from the prior year.
  • Shares Outstanding (Weighted Average) improved to $39.3 million in Q1 2026 per PEN's latest filing, from $38.9 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $39.3 million in Q1 2026 and troughed at $37.6 million in Q1 2022.
  • A 5-year average of $38.5 million and a median of $38.6 million in 2025 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) grew 3.55% in 2022, then fell 0.4% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $37.8 million in 2022, then gained by 1.48% to $38.4 million in 2023, then grew by 0.61% to $38.6 million in 2024, then climbed by 0.74% to $38.9 million in 2025, then advanced by 0.92% to $39.3 million in 2026.
  • Business Quant data shows PEN's Shares Outstanding (Weighted Average) at $39.3 million in Q1 2026, $38.9 million in Q4 2025, and $39.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.74 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 382.90 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 579.20 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 456.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 385.10 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 98.20 Mn
10 Penumbra 12.51 Bn 11.90 Bn 253.41 Mn 39.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 39.28 Mn
Dec 31, 2025 38.92 Mn
Sep 30, 2025 39.08 Mn
Jun 30, 2025 38.83 Mn
Mar 31, 2025 38.56 Mn
Dec 31, 2024 38.63 Mn
Sep 30, 2024 38.61 Mn
Jun 30, 2024 38.79 Mn
Mar 31, 2024 38.72 Mn
Dec 31, 2023 38.40 Mn
Sep 30, 2023 38.32 Mn
Jun 30, 2023 38.25 Mn
Mar 31, 2023 38.19 Mn
Dec 31, 2022 37.84 Mn
Sep 30, 2022 37.92 Mn
Jun 30, 2022 37.77 Mn
Mar 31, 2022 37.65 Mn
Dec 31, 2021 36.76 Mn
Sep 30, 2021 36.62 Mn
Jun 30, 2021 36.52 Mn